Table 2.
Inclusion criterion | Exclusion criterion |
---|---|
Known sources: HTA agencies, pharmaceutical companies, regulators, big consulting firms, patient organizations, and different initiatives | Unknown sources: small-sized pharmaceutical companies and small consulting firms |
Document published in English or German | Document in a different language |
Document focused on RWD or RWE in the healthcare context | Technical aspects of RWD or in different industries (other than healthcare) |
HTA, health technology assessment; RWD, real-world data; RWE, real-world evidence.